Biosimilars and Biomarkers In Drug Design

The discovery and evaluation of any novel biomarkers will ideally be focussed to Clinical Laboratory improvement amendments and  good  current laboratory standards, so as to ensure accuracy and reproducibility of laboratory procedures. Predictive biomarkers indicate the probability of response to a specific anti tumor therapy. Such assays should be scientifically sound, Analytical biomarkers include both tumor-specific and surrogate biomarkers, and are crucial to accelerating during the drug development process 
 

  • Biomarkers in pharmacovigilance and drug discovery
  • Biomarker Discovery for oncology and cardiology
  • Biomarkers of Toxicity & clinical trails

Related Conference of Biosimilars and Biomarkers In Drug Design

May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

4th International Conference on Pharmaceutical Chemistry

Bali, Indonesia
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE

Biosimilars and Biomarkers In Drug Design Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in